Using Vanrx Workcells, pharmaceutical companies can bring injectable medicines to market faster. Short changeover times and flexible systems enable agile manufacturing.
Vanrx Pharmasystems’ Microcell Vial Filler was hand-picked by industry magazine Pharmaceutical Manufacturing for a 2018 Pharma Innovation Award. This is the second award presented in 2018 to the Microcell Vial filler, following its Interphex ‘Best in show’ award in April.Read More
Singota Solutions recognized a gap in the market for contract aseptic filling services. They realized that companies developing new drug products and needing to fill batches of 20,000 units or less were underserved by contract manufacturing organizations. They chose Vanrx’s SA25 Aseptic Filling Workcell to provide an agile filling service for vials, syringes and cartridges, with short lead times.Read the case study
In 2010, Vanrx CEO Chris Procyshyn ‘wrote the book’ on the use of robotics in pharmaceutical manufacturing. His chapter “Isolated Robotics” in the publication Advanced Aseptic Processing Technology describes the ideal outcome of a digitally controlled, robotic, and flexible filling machine. In this blog post, we look at how those initial concepts have developed, and where we stand today on the use of robotics.Read More
The new white paper Aseptic Filling for Personalized Medicines describes a new solution for the aseptic filling of cell and gene therapies, immuno-oncology, mRNA and other modalities where manufacturing creates a therapy for a single patient.
A new gloveless robotic isolator for aseptic filling is particularly cost-effective and agile, helping companies process multiple patients per day within a single machine.Download the white paper
Sep 4 - Sep 7, 2018
Boston, MA, USA
Sep 26 - Sep 26, 2018
Foxborough, MA, USA
E152 (East Hall)
Oct 9 - Oct 11, 2018
Get a detailed view of how Aseptic Filling Workcells compare to conventional technologies and help bring drug products to market faster.Download the white paper
Our team members have developed and brought complex drug products to market. We know what you need now, and are designing for the future.